Biotech Giant Roche Accuses Indian Manufacturers of Counterfeiting Its Accu-Chek, Selling Them Fake Ones on Amazon

By

Biotech giant Roche claims that some Indian manufacturers and sellers are counterfeiting its Accu-Chek devices, which check blood glucose levels. The company accuses them of selling fake ones on Amazon.

Biotech Giant Roche Accuses Indian Manufacturers of Counterfeiting Its Accu-Chek, Selling Them Fake Ones on Amazon
David Burns, 38, who has type 1 diabetes, uses a device to measure blood sugar levels as he prepares to adminster himself a dose of insulin in his home in North London on February 24, 2019. NIKLAS HALLE'N/AFP via Getty Images

Biotech Giant Roche Accuses Indian Manufacturers of Counterfeiting Its Accu-Chek

Roche explained that sellers and manufacturers in India are selling counterfeit versions of its diabetes medical devices on Amazon. Because of this, the biotech firm filed a federal lawsuit, which was unsealed on Friday, June 7, as reported by CNBC.

"Patients know that Roche's Accu-Chek medical devices are safe, sterile, and accurate," complained the company.

However, Roche said that the Indian manufacturers and sellers are using expired or nearly expired Accu-Chek strips. It accuses them of repackaging the devices with fake labels bearing its registered US trademarks. The company also said that the counterfeiters include fake expiration dates.

Roche Warns Accu-Chek Users

According to NBC 5 Chicago's latest report, Roche warns consumers who are using its Accu-Chek devices that counterfeit ones are likely to give inaccurate measurements of blood glucose levels.

Roche added that this could put patients at risk of life-threatening complications. These include under-dosages and over-dosages of insulin, as well as hyperglycemia.

In Roche's lawsuit, four companies based in India were named as defendants. Their executives were also included in the case. As of press time, the biotech giant is seeking unspecified damages caused by the counterfeits.

Tags
Amazon

© 2024 VCPOST.com All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics